Cas no 294191-68-7 (1H-Diimidazo[1,2-a:4',5'-e]pyrazine(9CI))

1H-Diimidazo[1,2-a:4',5'-e]pyrazine(9CI) structure
294191-68-7 structure
Product Name:1H-Diimidazo[1,2-a:4',5'-e]pyrazine(9CI)
CAS No:294191-68-7
MF:C7H5N5
MW:159.148099660873
CID:249146
PubChem ID:57357906
Update Time:2025-04-19

1H-Diimidazo[1,2-a:4',5'-e]pyrazine(9CI) Chemical and Physical Properties

Names and Identifiers

    • 1H-Diimidazo[1,2-a:4',5'-e]pyrazine(9CI)
    • 1H-Diimidazo[1,2-a:4,5-e]pyrazine (9CI)
    • 3H-diimidazo[1,3-b:3',4'-e]pyrazine
    • DTXSID10723930
    • 294191-68-7
    • 3H-Diimidazo[1,2-a:4',5'-e]pyrazine
    • SCHEMBL20848249
    • Inchi: 1S/C7H5N5/c1-2-12-5(8-1)3-9-6-7(12)11-4-10-6/h1-4H,(H,10,11)
    • InChI Key: IGELYLIIHCGPRO-UHFFFAOYSA-N
    • SMILES: N12C=CN=C1C=NC1=C2N=CN1

Computed Properties

  • Exact Mass: 159.05465
  • Monoisotopic Mass: 159.05449518g/mol
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 1
  • Hydrogen Bond Acceptor Count: 3
  • Heavy Atom Count: 12
  • Rotatable Bond Count: 0
  • Complexity: 185
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 0
  • Undefined Atom Stereocenter Count : 0
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • Surface Charge: 0
  • Tautomer Count: 4
  • XLogP3: 0.9
  • Topological Polar Surface Area: 58.9?2

Experimental Properties

  • PSA: 58.87
Recommended suppliers
Beyond Pharmaceutical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Shenzhen Yaoyuan R&D Center Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shenzhen Yaoyuan R&D Center Co.,Ltd
Zouping Mingyuan Import and Export Trading Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zouping Mingyuan Import and Export Trading Co., Ltd
Changzhou Guanjia Chemical Co., Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Changzhou Guanjia Chemical Co., Ltd
Wuhan Comings Biotechnology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Wuhan Comings Biotechnology Co., Ltd.